SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-19-001060
Filing Date
2019-08-02
Accepted
2019-08-02 10:02:16
Documents
45
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q angiosoma20190630_10q.htm 10-Q 760242
2 EXHIBIT 31.1 ex_152271.htm EX-31.1 8543
3 EXHIBIT 32.1 ex_152272.htm EX-32.1 5504
10 logo.jpg GRAPHIC 12338
  Complete submission text file 0001185185-19-001060.txt   2928659

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT soan-20190630.xml EX-101.INS 403916
5 XBRL TAXONOMY EXTENSION SCHEMA soan-20190630.xsd EX-101.SCH 29633
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE soan-20190630_cal.xml EX-101.CAL 23418
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE soan-20190630_def.xml EX-101.DEF 162747
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE soan-20190630_lab.xml EX-101.LAB 240746
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE soan-20190630_pre.xml EX-101.PRE 166838
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 19994681
SIC: 2834 Pharmaceutical Preparations